These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of nanolipoprotein particles (NLPs) as an in vivo delivery platform. Fischer NO; Weilhammer DR; Dunkle A; Thomas C; Hwang M; Corzett M; Lychak C; Mayer W; Urbin S; Collette N; Chiun Chang J; Loots GG; Rasley A; Blanchette CD PLoS One; 2014; 9(3):e93342. PubMed ID: 24675794 [TBL] [Abstract][Full Text] [Related]
6. Lipid and Protein Transfer between Nanolipoprotein Particles and Supported Lipid Bilayers. Dang AT; He W; Ivey DB; Coleman MA; Kuhl TL Langmuir; 2019 Sep; 35(37):12071-12078. PubMed ID: 31442053 [TBL] [Abstract][Full Text] [Related]
7. Isolation, characterization, and stability of discretely-sized nanolipoprotein particles assembled with apolipophorin-III. Fischer NO; Blanchette CD; Segelke BW; Corzett M; Chromy BA; Kuhn EA; Bench G; Hoeprich PD PLoS One; 2010 Jul; 5(7):e11643. PubMed ID: 20657844 [TBL] [Abstract][Full Text] [Related]
8. Kinetics of lipid mixing between bicelles and nanolipoprotein particles. Lai G; Forti KM; Renthal R Biophys Chem; 2015 Feb; 197():47-52. PubMed ID: 25660392 [TBL] [Abstract][Full Text] [Related]
9. Nanolipoprotein Particles as a Delivery Platform for Fab Based Therapeutics. Darwish M; Shatz W; Leonard B; Loyet K; Barrett K; Wong JL; Li H; Abraham R; Lin M; Franke Y; Tam C; Mortara K; Zilberleyb I; Blanchette C Bioconjug Chem; 2020 Aug; 31(8):1995-2007. PubMed ID: 32701261 [TBL] [Abstract][Full Text] [Related]
10. Lipid Cross-Linking of Nanolipoprotein Particles Substantially Enhances Serum Stability and Cellular Uptake. Gilmore SF; Blanchette CD; Scharadin TM; Hura GL; Rasley A; Corzett M; Pan CX; Fischer NO; Henderson PT ACS Appl Mater Interfaces; 2016 Aug; 8(32):20549-57. PubMed ID: 27411034 [TBL] [Abstract][Full Text] [Related]
11. Integral membrane protein fragment recombination after transfer from nanolipoprotein particles to bicelles. Lai G; Renthal R Biochemistry; 2013 Dec; 52(52):9405-12. PubMed ID: 24328096 [TBL] [Abstract][Full Text] [Related]
12. Nanolipoprotein particles for co-delivery of cystine-knot peptides and Fab-based therapeutics. Darwish M; Gao X; Shatz W; Li H; Lin M; Franke Y; Tam C; Mortara K; Zilberleyb I; Hannoush RN; Blanchette C Nanoscale Adv; 2021 Jun; 3(13):3929-3941. PubMed ID: 36133017 [TBL] [Abstract][Full Text] [Related]
14. Impact of genetic deletion of platform apolipoproteins on the size distribution of the murine lipoproteome. Gordon SM; Li H; Zhu X; Tso P; Reardon CA; Shah AS; Lu LJ; Davidson WS J Proteomics; 2016 Sep; 146():184-94. PubMed ID: 27385375 [TBL] [Abstract][Full Text] [Related]
16. Stability of mRNA/cationic lipid lipoplexes in human and rat cerebrospinal fluid: methods and evidence for nonviral mRNA gene delivery to the central nervous system. Anderson DM; Hall LL; Ayyalapu AR; Irion VR; Nantz MH; Hecker JG Hum Gene Ther; 2003 Feb; 14(3):191-202. PubMed ID: 12639300 [TBL] [Abstract][Full Text] [Related]
17. Correlation of structural stability with functional remodeling of high-density lipoproteins: the importance of being disordered. Guha M; Gao X; Jayaraman S; Gursky O Biochemistry; 2008 Nov; 47(44):11393-7. PubMed ID: 18839964 [TBL] [Abstract][Full Text] [Related]
18. Crystallization of ApoA1 and ApoE4 nanolipoprotein particles and initial XFEL-based structural studies. Shelby ML; Gilbile D; Grant TD; Bauer WJ; Segelke B; He W; Evans AC; Crespo N; Fischer P; Pakendorf T; Hennicke V; Hunter MS; Batyuk A; Barthelmess M; Meents A; Kuhl TL; Frank M; Coleman MA Crystals (Basel); 2020 Oct; 10(10):. PubMed ID: 35686136 [TBL] [Abstract][Full Text] [Related]
19. In vivo lipoprotein binding assay of the insect exchangeable apolipoprotein, apolipophorin-III. Chetty PS; Arrese EL; Soulages JL Protein Pept Lett; 2003 Oct; 10(5):469-73. PubMed ID: 14561135 [TBL] [Abstract][Full Text] [Related]